[Insulin resistance in overweight cystic fibrosis paediatric patients]

An Pediatr (Barc). 2012 May;76(5):279-84. doi: 10.1016/j.anpedi.2011.11.016. Epub 2012 Jan 9.
[Article in Spanish]

Abstract

Aim: To determine the prevalence of overweight in paediatric patients with cystic fibrosis (CF) and to analyse its role as diabetogenic insulin resistance factor and risk of hypertriglyceridaemia.

Patients and methods: A total of 109 CF patients (47% males) between 5 and 18 years were divided into 3 groups according to body mass index (BMI): underweight, normal and overweight. Total cholesterol, triglycerides, C- reactive protein (CRP), glycosylated haemoglobin, HOMA-IR and QUICKI index were determined. Insulinogenic index, ISI composite and areas under the curve (AUC) for glucose and insulin were obtained by oral glucose tolerance test (OGTT).

Results: Six patients (5.5%) were overweight. All groups had similar distribution by age, sex and CFTR mutation, although the proportion of pancreatic sufficient (3/6, 50%) was higher in overweight patients (P=.003). The prevalence of glycaemic disorders was similar between groups. Baseline insulin, HOMA-IR, and insulin during the OGTT (peak and AUC) were higher in overweight patients. All patients had a delayed insulin response in OGTT.

Conclusions: Overweight CF patients do not have a higher incidence of glycaemic disorders, but their hyperinsulinism and insulin resistance may be additional diabetogenic risk factors.

Publication types

  • English Abstract
  • Multicenter Study

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / metabolism*
  • Female
  • Humans
  • Hypertriglyceridemia / complications
  • Hypertriglyceridemia / metabolism
  • Insulin Resistance*
  • Male
  • Overweight / epidemiology
  • Overweight / etiology*
  • Overweight / metabolism*
  • Prevalence
  • Risk Factors